Effects of an NO-synthase inhibitor L-NMMA in the hepatopulmonary syndrome.
Maniscalco
M
M
Sofia
M
M
Higenbottam
T
T
D000328:Adult; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D020065:Hepatopulmonary Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008297:Male; D019323:omega-N-Methylarginine / Q000627:therapeutic use*
D004791:Enzyme Inhibitors; D019323:omega-N-Methylarginine